88 related articles for article (PubMed ID: 7693579)
41. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
42. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
43. Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features.
Cuneo A; Ferrant A; Michaux JL; Demuynck H; Boogaerts M; Louwagie A; Doyen C; Stul M; Cassiman JJ; Dal Cin P; Castoldi G; Van den Berghe H
Haematologica; 1996; 81(5):423-7. PubMed ID: 8952155
[TBL] [Abstract][Full Text] [Related]
44. The in-vitro response of CD2-positive acute myelogenous leukemia to proliferation and differentiation inducing agents.
Traweek ST; Ben-Ezra J; Braziel RM; Winberg CD
Leuk Res; 1990; 14(5):433-40. PubMed ID: 1693168
[TBL] [Abstract][Full Text] [Related]
45. Cell surface markers of acute non-lymphocytic leukemias: leukemia type and its expression of C3 and Fc receptors.
Motoji T; Musashi M; Shimoyama M; Mizoguchi H; Miyazaki T
Hokkaido Igaku Zasshi; 1986 May; 61(3):412-8. PubMed ID: 3527921
[TBL] [Abstract][Full Text] [Related]
46. Genuine CD7 expression in acute leukemia and lymphoblastic lymphoma.
Osada H; Emi N; Ueda R; Seto M; Koike K; Suchi T; Kojima S; Obata Y; Takahashi T
Leuk Res; 1990; 14(10):869-77. PubMed ID: 1701841
[TBL] [Abstract][Full Text] [Related]
47. [Morphological classification of acute myeloid leukemias using the FAB system. Retrospective analysis of 106 cases].
Reiffers J; Dachary D; Bernard P; Veyret V; Boisseau MR; Broustet A
Nouv Rev Fr Hematol (1978); 1982; 24(4):237-40. PubMed ID: 6959074
[TBL] [Abstract][Full Text] [Related]
48. Clinical and biologic characteristics of CD7+ acute myeloid leukemia. Our experience and literature review.
Shimamoto T; Ohyashiki JH; Ohyashiki K; Kawakubo K; Inatomi Y; Fujieda H; Nakazawa S; Kimura N; Miyauchi J; Toyama K
Cancer Genet Cytogenet; 1994 Mar; 73(1):69-74. PubMed ID: 7513604
[TBL] [Abstract][Full Text] [Related]
49. Cytomorphological and cytochemical classification of acute myeloid leukaemia (AML).
Maras J; Hauptmann E; Crepinko I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):474-7. PubMed ID: 2431968
[TBL] [Abstract][Full Text] [Related]
50. [Characterization of morphologic, cytochemical and immunological features in myeloperoxidase negative acute myeloid leukaemia].
Ai HS; Cao LX; Pian HY
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):246-9. PubMed ID: 8156851
[TBL] [Abstract][Full Text] [Related]
51. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Masi M; Papa G
Blood; 1993 Nov; 82(9):2929-30. PubMed ID: 7693052
[No Abstract] [Full Text] [Related]
52. CD7 expression does not affect the prognosis in acute myeloid leukemia.
Lauria F; Raspadori D; Ventura MA; Rondelli D; Tura S
Blood; 1994 May; 83(10):3097-8. PubMed ID: 7514052
[No Abstract] [Full Text] [Related]
53. CD7 (GP40) false-positive acute myelogenous leukemia and promyelocytic leukemia cell line HL-60.
Imamura N; Mtasiwa D; Kuramoto A
Leuk Res; 1991; 15(4):277-8. PubMed ID: 1709431
[No Abstract] [Full Text] [Related]
54. The importance of CD7 and CD56 antigens in acute leukaemias.
Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
[TBL] [Abstract][Full Text] [Related]
55. [Immunophenotypic heterogeneity of CD7+CD4-CD8--acute leukemia].
Abramenko IV; Belous NI; Skliarenko LM; Nadgornaia VA
Gematol Transfuziol; 1995; 40(4):10-3. PubMed ID: 7557227
[TBL] [Abstract][Full Text] [Related]
56. A case of peroxidase-positive acute leukaemia expressing only T lineage lymphoid markers.
Lelong F; Chretien P; Jouault H; Bayani N; Bernaudin F; Lemerle S
Br J Haematol; 1994 Jan; 86(1):195-7. PubMed ID: 8011530
[TBL] [Abstract][Full Text] [Related]
57. [Ultrastructural peroxidases and immunological markers in acute adult leukaemia: therapeutic applications (author's transl)].
Marie JP; Escribano L; Perrot JY; Boucheix C; Kayibanda M; Martyre MC; Cadiou M; Rosenfeld C; Zittoun R
Nouv Presse Med; 1982 May; 11(21):1603-6. PubMed ID: 7048250
[TBL] [Abstract][Full Text] [Related]
58. [Morphocytochemical and immunological criteria for the diagnosis and prognosis of the course of acute myelogenous. leukemias].
Shakhbazian GP; Dul'tsina SM; Potapova SG; Abakumov EM; Isaev VG
Probl Gematol Pereliv Krovi; 1982 Nov; 27(11):17-22. PubMed ID: 6961396
[No Abstract] [Full Text] [Related]
59. Prognostic significance of morphological and cytochemical markers in adult acute myelogenous leukaemia: concepts and observations.
George E; Kamarulzaman E
Med J Malaysia; 1979 Dec; 34(2):184-6. PubMed ID: 297198
[No Abstract] [Full Text] [Related]
60. [Experience with the use of aseptic isolator in the prevention of infections in patients with acute non-lymphocytic leukemia].
Delsignore R; Rossi G; Baroni MC; Butturini U
G Clin Med; 1977; 58(1-2):59-70. PubMed ID: 269090
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
